Literature DB >> 20642359

Risk of myocardial infarction related to factor V Leiden mutation: a meta-analysis.

Moataz Dowaidar1, Ahmad Settin.   

Abstract

BACKGROUND: Myocardial infarction (MI) can be due to inherited thrombophilia caused by resistance to activated protein C resulting from factor V Leiden (FVL) mutation.
OBJECTIVES: The objectives of this study were to estimate the frequency of FVL mutation among MI cases in various populations and calculate the overall risk related to it. SUBJECTS AND METHODS: Subjects comprised 7790 cases with MI and 19,276 healthy controls collected from 41 relevant studies in the search databases. The resulting frequency of FVL mutation among cases and the odds ratio were compared and integrated in a meta-analysis format.
RESULTS: Although there was marked variation of the frequency of FVL mutation among different populations including MI and healthy controls, most studies reported a positive risk related to it. Compilation of analyzed studies resulted in an overall frequency of FVL mutation of 6.791% among MI cases, which was significantly higher than that among controls (1.304%, p = 0.0) with an overall odds ratio of 1.608 (95% confidence interval, 1.98-4.44).
CONCLUSION: There is a definite risk related to the carriage of FVL mutation among MI cases. This should have a potential impact on the genetic counseling of family members of affected cases for proper prophylaxis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20642359     DOI: 10.1089/gtmb.2010.0017

Source DB:  PubMed          Journal:  Genet Test Mol Biomarkers        ISSN: 1945-0257


  7 in total

1.  Systems analysis of gene ontology and biological pathways involved in post-myocardial infarction responses.

Authors:  Nguyen T Nguyen; Merry L Lindsey; Yu-Fang Jin
Journal:  BMC Genomics       Date:  2015-06-11       Impact factor: 3.969

2.  Multiple thrombophilia mutations as a possible cause of premature myocardial infarction.

Authors:  Gabriela Dostálová; Jan Bělohlávek; Zuzana Hlubocká; Kristýna Bayerová; Petra Bobčiková; Tomáš Kvasnička; Jan Kvasnička; Aleš Linhart; Debora Karetová
Journal:  Wien Klin Wochenschr       Date:  2017-04-05       Impact factor: 1.704

3.  A haplotype of the GOSR2 gene is associated with myocardial infarction in Japanese men.

Authors:  Shuo Pan; Tomohiro Nakayama; Naoyuki Sato; Yoichi Izumi; Masayoshi Soma; Noriko Aoi; Yitong Ma; Shigeaki Hinohara; Nobutaka Doba
Journal:  Genet Test Mol Biomarkers       Date:  2013-05-15

4.  Meta-analysis of Factor V Leiden G1691A polymorphism and osteonecrosis of femoral head susceptibility.

Authors:  Xifu Shang; Zhengliang Luo; Xu Li; Fei Hu; Qichun Zhao; Wenzhi Zhang
Journal:  Biomed Rep       Date:  2013-04-09

5.  Additional Utility of Pharmacogenomics (PGx) Panel Testing in a CYP2D6 Normal Metabolizer with a History of Breast Cancer.

Authors:  Michael J Schuh
Journal:  Innov Pharm       Date:  2019-07-18

6.  Free protein S level as a risk factor for coronary heart disease and stroke in a prospective cohort study of healthy United Kingdom men.

Authors:  Gie Ken-Dror; Jackie A Cooper; Steve E Humphries; Fotios Drenos; Helen A Ireland
Journal:  Am J Epidemiol       Date:  2011-09-12       Impact factor: 4.897

7.  Myocardial infarction, prothrombotic genotypes, and venous thrombosis risk: The Tromsø Study.

Authors:  Joakim K Sejrup; Vania M Morelli; Maja-Lisa Løchen; Inger Njølstad; Ellisiv B Mathiesen; Tom Wilsgaard; John-Bjarne Hansen; Sigrid K Brækkan
Journal:  Res Pract Thromb Haemost       Date:  2020-01-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.